Stem cell research collaborative funding agreements

CIRM Collaborative Funding

CIRM has collaborative relationships with the following governmental agencies:

  • Agence Nationale de la Recherche, France
  • AIDS Healthcare Foundation
  • Andalusian Initiative for Advanced Therapies, Spain
  • Argentina (MINCYT)
  • Brazil (CNPq)
  • Cancer Stem Cell Consortium, Canada
  • Chinese Ministry of Science and Technology (MOST)
  • Federal Ministry of Education and Research, Germany
  • Japan Science and Technology Agency, Japan
  • Juvenile Diabetes Research Foundation
  • Keystone Symposia of Molecular and Cellular Biology
  • India (inSTEM)
  • Maryland Technology Development Corporation, Maryland, U.S.
  • Medical Research Council, UK
  • Ministry of Science and Innovation, Spain
  • Muscular Dystrophy Association
  • National Health and Medical Research Council, Australia
  • National Institutes of Health (NIH)
  • New York Stem Cell Foundation
  • São Paulo (Brazil) Research Foundation (FAPESP)
  • Scottish Enterprise, Scotland
  • Victoria, Australia

See a list of all awards with collaborative funding partners

Why form collaborative partnerships

The California Institute for Regenerative Medicine funds research carried out in California. However, excellent stem cell science is taking place worldwide. Our collaborative funding relationships facilitate work between Californian scientists and their innovative colleagues around the globe. The program provides a mechanism for funding partnerships in which CIRM funds the California scientists while our funding partners support researchers in their jurisdictions.

Collaborative funding of research groups optimizes the use of resources, avoids duplication and creates a critical mass of excellence across a wide range of specialties worldwide. For CIRM grantees, the program expands the number of scientists with whom they can work and mitigates the geographic limitations imposed by CIRM’s funding.

How the agreements work 

CIRM’s staff constantly monitors scientific developments and challenges to identify funding areas that most effectively advance the Institute’s mission. That analysis results in Requests for Applications (“RFA”) which notify California scientists of the work the Institute wishes to fund. CIRM also consults with its collaborative funding partners, sharing ideas about priorities and funding strategies. If there is an alignment of interest between CIRM and a funding partner, that partner can commit funds to the RFA. Researchers from the partner’s state or country may then be included on collaborative applications with California researchers.

Applications that include collaborative co-investigators must satisfy the CIRM eligibility and other criteria for their specific RFA. Additionally, our funding partners may impose their own criteria for funding projects.

The application process can involve a pre-application followed by an invitation to some applicants to submit full applications, which undergo review by 15 members of CIRM’s Scientific and Medical Research Funding Working Group. The Grants Working Group scores the applications according to established criteria and provides recommendations to CIRM’s 29-member governing board. The governing board has the final authority to choose which applications to fund.

Proposed collaborative projects are evaluated along with all other applications. They are neither favored nor disfavored in the evaluation process. Any competitive advantage they enjoy must stem from the unique combination of excellent scientists or resources that, but for the collaborative program, could not be funded by CIRM.

If the governing board approves funding for an application that includes an international researcher, CIRM’s collaborative funding partner would be responsible for funding the international portion of the research. For those grants, CIRM monitors the research progress in cooperation with the funding partner.

How to apply for collaborative funding

Researchers in countries that have collaborative funding agreements with CIRM can only participate in RFAs in which their country has committed funds.

If a commitment has been made, researchers in California can contact colleagues in the committed funding partner’s jurisdiction; similarly researchers in the funding partner jurisdiction can contact colleagues in California to submit a collaborative application.

The process for submitting collaborative applications will differ for each round of funding. Please see the specific RFA for information on how to apply collaboratively.

 

© 2013 California Institute for Regenerative Medicine